charles khouri
机构: Pharmacologist, Grenoble Alpes University Hospital
每年引用次数
引用次数
引用: 1,563
H-指数: 23
I10-指数 : 38
出版物: 156
Fluoxetine and Raynaud's phenomenon: friend or foe?
Charles Khouri , Thomas Gailland , Marion Lepelley , Matthieu Roustit
British Journal of Clinical Pharmacology 83 ( 10) 2307 -2309
1
2017
Severe central sleep apnoea associated with nalmefene: a case report.
Charles Khouri , François Arbib , Bruno Revol , Jean-Louis Pepin
British Journal of Clinical Pharmacology 84 ( 5) 1075 -1076
2
2018
Proton pump inhibitors and Raynaud's phenomenon: is there a link?
Charles Khouri , Bruno Revol , Jean-Luc Cracowski , Matthieu Roustit
British Journal of Clinical Pharmacology 84 ( 10) 2443 -2444
1
2018
Which opioids in case of mast cell activation disorders
Marion Lepelley , Charles Khouri , Pauline Pralong , Julien Rossignol
The Journal of Allergy and Clinical Immunology: In Practice 7 ( 4) 1317 -1318
1
2019
Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor-induced angioedema: A disproportionality analysis of the WHO pharmacovigilance database.
Marion Lepelley , Charles Khouri , Clémence Lacroix , Laurence Bouillet
The Journal of Allergy and Clinical Immunology: In Practice 8 ( 7)
1
2020
Pharmacologie du phénomène de Raynaud
Matthieu Roustit , Charles Khouri , Sophie Blaise , Céline Villier
Therapie 69 ( 2) 115 -128
2
2014
Antidépresseurs et tamoxifène : une interaction méconnue
Mélanie Moulis , Charles Khouri , Michel Mallaret
Therapie 69 ( 2) 178 -179
2014
Dysthyroidie sous anti-VEGF, effet indésirable de classe ? À propos d’un cas
Charles Khouri , Elodie Jean Bart , Sophie Logerot , Amandine Decker-Bellaton
Therapie 69 ( 6) 521 -524
1
2014
SGLT-2 inhibitors and the risk of lower-limb amputation: Is this a class effect?
Charles Khouri , Jean-Luc Cracowski , Matthieu Roustit
Diabetes, Obesity and Metabolism 20 ( 6) 1531 -1534
51
2018
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.
Louis Larrouquere , Manon Gabin , Emmanuelle Poingt , Amelle Mouffak
Fundamental & Clinical Pharmacology 34 ( 3) 389 -396
26
2020
Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials
Charles Khouri , Marion Lepelley , Sebastien Bailly , Sophie Blaise
The Lancet Rheumatology 1 ( 4)
9
2019
Treatment efficacy in secondary Raynaud's phenomenon – Authors' reply
Matthieu Roustit , Charles Khouri , Jean-Luc Cracowski
The Lancet Rheumatology 2 ( 3)
2020
On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials.
Matthieu Roustit , Joris Giai , Olivier Gaget , Charles Khouri
Annals of Internal Medicine 169 ( 10) 694 -703
11
2018
Hierarchical evaluation of electrical stimulation protocols for chronic wound healing: An effect size meta‐analysis
Charles Khouri , Sylvain Kotzki , Matthieu Roustit , Sophie Blaise
Wound Repair and Regeneration 25 ( 5) 883 -891
13
2017
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study
Lucie Cornet , Charles Khouri , Matthieu Roustit , Christophe Guignabert
European Respiratory Journal 53 ( 5) 1802472
16
2019
Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey.
Margaux Lafaurie , Pascale Olivier , Charles Khouri , Marina Atzenhoffer
European Journal of Clinical Pharmacology 76 ( 4) 603 -604
1
2020
Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.
Charles Khouri , Sophie Blaise , Patrick Carpentier , Céline Villier
British Journal of Clinical Pharmacology 82 ( 1) 6 -16
20
2016
Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.
Charles Khouri , Thomas Jouve , Sophie Blaise , Patrick Carpentier
British Journal of Clinical Pharmacology 82 ( 2) 549 -560
8
2016
Leveraging the variability of pharmacovigilance disproportionality analyses to improve signal detection performances
Charles Khouri , Thuy Nguyen , Bruno Revol , Marion Lepelley
Frontiers in Pharmacology 12 668765
11
2021
Validity, relevance and interpretation of pharmacovigilance disproportionality analyses.
Benjamin Cortes , Clément Jambon-Barbara , Jean-Luc Cracowski , Charles Khouri
Bone 116685 -116685
2023